These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 27094609)

  • 41. Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia.
    Maynard SE; Venkatesha S; Thadhani R; Karumanchi SA
    Pediatr Res; 2005 May; 57(5 Pt 2):1R-7R. PubMed ID: 15817508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A; Rana S; Karumanchi SA
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling.
    Zhou CC; Ahmad S; Mi T; Abbasi S; Xia L; Day MC; Ramin SM; Ahmed A; Kellems RE; Xia Y
    Hypertension; 2008 Apr; 51(4):1010-9. PubMed ID: 18259044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiogenic factors and preeclampsia.
    Steinberg G; Khankin EV; Karumanchi SA
    Thromb Res; 2009; 123 Suppl 2():S93-9. PubMed ID: 19217486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Nitric Oxide, ADMA, and Homocysteine in The Etiopathogenesis of Preeclampsia-Review.
    Dymara-Konopka W; Laskowska M
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Astragaloside IV ameliorates preeclampsia-induced oxidative stress through the Nrf2/HO-1 pathway in a rat model.
    Yang S; Zhang R; Xing B; Zhou L; Zhang P; Song L
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E904-E911. PubMed ID: 32924527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities.
    Pérez-Roque L; Núñez-Gómez E; Rodríguez-Barbero A; Bernabéu C; López-Novoa JM; Pericacho M
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aetiology and physiopathology of preeclampsia and related forms.
    Lorquet S; Pequeux C; Munaut C; Foidart JM
    Acta Clin Belg; 2010; 65(4):237-41. PubMed ID: 20954461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preeclampsia: new insights.
    Shah DM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):213-20. PubMed ID: 17420664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.
    Burke SD; Zsengellér ZK; Khankin EV; Lo AS; Rajakumar A; DuPont JJ; McCurley A; Moss ME; Zhang D; Clark CD; Wang A; Seely EW; Kang PM; Stillman IE; Jaffe IZ; Karumanchi SA
    J Clin Invest; 2016 Jul; 126(7):2561-74. PubMed ID: 27270170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Mechanisms of Preeclampsia.
    Hod T; Cerdeira AS; Karumanchi SA
    Cold Spring Harb Perspect Med; 2015 Aug; 5(10):. PubMed ID: 26292986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pre-eclampsia: clinical manifestations and molecular mechanisms.
    Baumwell S; Karumanchi SA
    Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
    Boulanger H; Lefèvre G; Ahriz Saksi S; Achiche J; Bailleul S; Ekoukou D; Drouin D; Sault C; Stawiarski N; Dupuis E
    Nephrol Ther; 2019 Nov; 15(6):413-429. PubMed ID: 30935786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Major changes in diagnosis and management of preeclampsia.
    Snydal S
    J Midwifery Womens Health; 2014; 59(6):596-605. PubMed ID: 25377651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular Sequels During and After Preeclampsia.
    Paauw ND; Lely AT
    Adv Exp Med Biol; 2018; 1065():455-470. PubMed ID: 30051401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications.
    Ahmed A
    Thromb Res; 2011 Feb; 127 Suppl 3():S72-5. PubMed ID: 21262447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.